Clinical Spectrum of Raynaud's Phenomenon in Patients Referred to Vascular Clinic

Vascular

Volumn 8, Issue 6, 2000, Pages 457-462

  Knapik Kordecka, M ^a   Wysokinski, W E ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

anticardiolipin antibodies; Raynaud's phenomenon; vascular medicine

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; BUERGER DISEASE; CHILD; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER MALFORMATION; GANGRENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; RISK FACTOR; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; TOE MALFORMATION; VASOSPASM;

ADULT; AGED; AUTOANTIBODIES; CARDIOLIPINS; CASE-CONTROL STUDIES; CAUSALITY; CHILD; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RAYNAUD'S DISEASE;

EID: 0033825145     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090000800610     Document Type: Article

References (40)

1. Maricq, H.R. Weinberger, A.B. LeRoy, E.C. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. Journal of Rheumatology, 1982, 9, 289-291.
2. Zufferey, P. Depairon, M. Chamot, A.M. et al. Prognostic significance of nailfold capillary microscopy in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Annals of Rheumatic Disease, 1988, 47, 634-641.
3. Wollersheim, H. Thien, T. Hoet, M.H. et al. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of CTD in patients presenting with Raynaud's phenomenon. European Journal of Clinical Investigation, 1989, 19, 535-541.
4. Genetric, A. Blaschek, M.A. LeNoach, J.F. et al. Serological arguments for classifying Raynaud's phenomenon as idiopathic. Journal of Rheumatology, 1990, 17, 1177-1181.
5. Weiner, E.S. Hildebrandt, S. Senecal, J.L. et al. Prognostic significance of anticentromere antibodies and anti-tropoisomerase I antibodies in Raynaud's disease: a prospective study. Arthritis and Rheumatism, 1991, 34, 68-77.
6. Landry, G.J. Edwards, J.M. McLafferty, R.B. et al. Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort. Journal of Vascular Surgery, 1996, 23, 76-85.
7. Gerbracht, D.D. Steen, V.D. Ziegler, G.L. et al. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to CTD. Arthritis and Rheumatism, 1985, 28, 87-92.
8. FitzGerald, O. Hess, E.V. O'Connor, G.T. et al. Prospective study of the evolution of Raynaud's phenomenon. American Journal of Medicine, 1988, 84, 718-726.
9. Hirschl, M. Kundi, M. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology. Journal of Rheumatology, 1996, 23, 302-309.
10. Spencer-Green, G. Outcomes in primary Raynaud phenomenon. Archives of International Medicine, 1998, 158, 595-600.
11. Allen, E.V. Brown, G.E. Raynaud's disease: a critical review of minimal requisites for diagnosis. American Journal of Medical Science, 1932, 183, 187-192.
12. Porter, J.M. Rivers, S.P. Anderson, C.J. et al. Evaluation and management of patients with Raynaud's syndrome. American Journal of Surgery, 1981, 142, 183-189.
13. Wollersheim, H. Thien, T. The diagnostic value of clinical signs and symptoms patients with Raynaud's phenomenon. A cross-sectional study. Netherlands Journal of Medicine, 1990, 37, 171-182.
14. Maricq, H.R. Spencer-Green, G. LeRoy, E.C. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. American Journal of Medicine, 1976, 61, 862-870.
15. Masi, A.T. Rodnan, G.P. Medsger, T.A. Jr. et al. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism, 1980, 23, 581-590.
16. Tan, E.M. Cohen, A.S. Fries, J.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 1982, 25, 1271-1277.
17. Amett, F.C. Edworthy, S.M. Bloch, D.A. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 1988, 31, 315-324.
18. Vitali, C. Bombardieri, S. Moutsopoulos, H.M. et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis and Rheumatism, 1993, 36, 340-347.
19. Sharp, G.C. Irvin, W.S. Tan, E.M. et al. Mixed CTD: an apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA). American Journal of Medicine, 1972, 52, 148-154.
20. Nelson, R.M. Davis, R.W. Thoracic outlet compression syndrome: collective review. Annals of Thoracic Surgery, 1966, 8, 437-442.
21. Brubaker, R.L. Mackenzie, C.J. Hutton, S.G. Vibration induced white finger among selected underground rock drillers in British Columbia. Scandinavian Journal of Work and Environmental Health, 1986, 12, 296-300.
22. Savader, S.J. Savader, B.L. Drewry, G.R. Hypothenar hammer syndrome with embolic occlusion of digital arteries. Clinical Radiology, 1988, 39, 324-325.
23. Wysokinski, W.E. Kwiatkowska, W. Sapian-Raczkowska, B. et al. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger's disease). Angiology, 2000, 51, 141-150.
24. Loizou, S. McCrea, J.D. Rudge, A.C. et al. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clinical and Experimental Immunology, 1985, 62, 738-745.
25. Vayssairat, M. Baudot, N. Gaitz, J.P. Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease. Journal of the American Academy of Dermatology, 1995, 32, 747-749.
26. Riera, G. Vilardell, M. Vaque, J. et al. Prevalence of Raynaud's phenomenon in healthy Spanish population. Journal of Rheumatology, 1993, 20, 66-69.
27. Inaba, R. Maeda, M. Fujita, S. et al. Prevalence of Raynaud's phenomenon and specific clinical signs related to progressive systemic sclerosis in the general population of Japan. International Journal of Dermatology, 1993, 32, 652-655.
28. Brandt, F.N. Larson, M.G. Kannel, W.B. et al. The occurrence of Raynaud's phenomenon in a general population: the Framingham Study. Vascular Medicine, 1997, 2, 296-301.
29. Priollet, P. Vayssairat, M. Housset, E. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. American Journal of Medicine, 1987, 83, 494-498.
30. Planchon, B. Pistorius, M.A. Beurrier, P. et al. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology, 1994, 45, 677-686.
31. Houtman, P.M. Kallenberg, C.G. Fidler, V. et al. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. Journal of Rheumatology, 1986, 13, 556-563.
32. Grassi, W. De Angelis, R. Lapadula, G. et al. Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study. Rheumatology International, 1998, 18, 17-20.
33. Fitzgerald, O. Hess, E.V. O'Connor, G.T. et al. Prospective study of the evolution of Raynaud's phenomenon. American Journal of Medicine, 1988, 84, 718-726.
34. Ohtsuka, T. Tamura, T. Yamakage, A. et al. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. British Journal of Dermatology, 1998, 139, 622-629.
35. Dimant, J. Ginzler, E. Schlesinger, M. et al. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Arthritis and Rheumatism, 1979, 22, 815-819.
36. Ansari, A. Larson, P.H. Bates, H.D. Vascular manifestations of systemic lupus erythematosus. Angiology, 1986, 37, 423-432.
37. Costallat, L.T. Coimbra, A.M. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clinical and Experimental Rheumatology, 1994, 12, 603-607.
38. Shionoya, S. Buerger's disease: diagnosis and management. Cardiovascular Surgery, 1993, 1, 207-214.
39. Alarcon-Segovia, D. Deleze, M. Oria, C. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a review of 500 consecutive cases. Medicine, 1989, 68, 353-365.
40. Vayssairat, M. Abuaf, N. Baudot, N. et al. Abnormal IgG cardiolipin antibody titers in patients with Raynaud's phenomenon and/or related disorders: prevalence and clinical significance. Journal of the American Academy of Dermatology, 1998, 38, 555-558.